Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mylan Inc. released the following response to a news article published earlier: "An article published about an issue related to a Standard Operating Procedure was based on improperly obtained documents, uninformed third–party commentary and anonymous sources. Simply put, our investigation of the issue demonstrates that our quality systems are working, not the contrary. Our customers and stakeholders can rest assured that whenever there is even the slightest departure from an SOP, it will be dealt with immediately and effectively. This issue had no impact on the quality of our product."

Today in Popular Press...keeping you current

A look at how far hospitals have come since To Err is Human report
American Hospital Association News, 11/25/09

AstraZeneca and the Philadelphia Department of Public Health provide free medicines to Pennsylvanias uninsured
AstraZeneca, 11/24/09

Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Amgen, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address